Griffith University

Elke Kaemmerer

Name: Elke Kaemmerer
Position: Research Fellow
Research Area: Cancer Drug Discovery
Qualifications: Diploma in Biology (equivalent to M.Sc.), Doctor of Natural Sciences (equivalent to PhD)

Elke graduated in 2010 from the Technische Universität (TU) Darmstadt, Germany, with a Diploma in Biology (equivalent to M.Sc.) and in 2014 was awarded a Doctor of Natural Sciences (equivalent to PhD degree) from TU Darmstadt, Department of Biology. Her PhD project investigated a bioengineered 3D cell culture system for ovarian cancer research and high resolution microscopy. She conducted research for her PhD project in Germany and Australia at the Department of Biology at TU Darmstadt and the Institute of Health and Biomedical Innovation at QUT, Australia. Upon completion of her PhD degree, Elke was a Research Fellow at the School of Pharmacy at UQ, with a research focus on calcium channels and pumps as novel targets to overcome therapeutic resistance in breast cancer. Elke joined the Discovery Biology team in July 2016 as part of the Cancer Therapeutics initiative.

Discovery Biology


Kaemmerer E, Loessner D and Avery VM. Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel targets for cancer therapy. Drug Discovery Today. [Review] 2021 Mar; 26(3): 663-676.

Kaemmerer E, Rodriguez Garzon TE, Lock AM, Lovitt CJ and Avery VM. Innovative in vitro models for breast cancer drug discovery. Drug Discovery Today: Disease Models.  Invited review article. 2017 March 18; 21: 11-16.


2019:  GRIDD Collaborative Industry Grant, joint winner for project with Inventia Life Science

2019: Griffith University 3Rs award for research activities into 3D models for pancreatic cancer

2019: BRIDGE program, selected participant and program completion; receiving training in translation and commercialisation of medicines; BRIDGE program, Australia

2019:  BRIDGE program, travel support from GRIDD, Griffith University, Australia

2018: CTx platinum award, for major contribution to the development of a cost-effective high throughput assay for a CTx drug discovery program

2018: Tony B. Academic Travel Award to attend the Society of Laboratory Automation and Screening International Conference and Exhibition; San Diego, USA

2016: Cancer Therapeutics CRC Award to attend the Oncology Drug Development in Practice course; Amsterdam, Netherlands

Committees and Memberships:

Member: Women in Technology (WiT) Life Sciences Committee

Member: Society for Laboratory Automation and Screening (SLAS)



Kaemmerer  E, Turner D, Peters AA, Roberts-Thomson SJ, Monteith, GR (2018). ‘An automated epifluorescence microscopy imaging assay for the identification of phospho-AKT level modulators in breast cancer cells ’ Journal of pharmacological and toxicological methods 92 (2018): 13-19.

Azimi I, Milevskiy MJG, Kaemmerer E, Turner D, Yapa KTDS, Brown MA, Thompson EW, Roberts-Thomson SJ, Monteith GR (2017), ‘TRPC1 is a differential regulator of hypoxia-mediated events and Akt signaling in PTEN-deficient breast cancer cells’. J Cell Sci (2017): jcs-196659. 2017 May 23.

Pera E1, Kaemmerer E1, Milevskiy MJG, Yapa KTDS, O’Donnell JS, Brown MA, Simpson F, Peters AA, Roberts-Thomson SJ, Monteith GR (2016). ‘The voltage gated Ca(2+)-channel Cav3.2 and therapeutic responses in breast cancer’. Cancer Cell Int. 2016 Mar 31,16:24.

Loessner D, Meinert C, Kaemmerer E, Martine LC, Yue K, Levett PA, Klein TJ, Melchels FPW, Khademhosseini A, Hutmacher DW (2016). ‘Functionalization, preparation and use of cell-laden gelatin methacryloyl–based hydrogels as modular tissue culture platforms.’ Nature Protoc. 2016 Apr 11(4) 727-46. Epub 2016 Mar 17.

Holzapfel NP, Holzapfel BM, Theodoropoulos C, Kaemmerer E, Rausch T, Feldthusen J, Champ S, Clements JA, Hutmacher DW, Loessner D (2016).  ‘Lycopene’s effects on cancer cell functions within monolayer and spheroid cultures’. Nutr Cancer 2016, 68(2):350-63. Epub 2016 Mar 25.

Lauer FM1, Kaemmerer E1, Meckel T. (2014) ‘Single molecule microscopy in 3D cell cultures and tissues’. Adv Drug Deliv Rev. 2014 Dec 15;79-80:79-94. Epub 2014 Oct 18. Invited review article.

Kaemmerer E, Melchels FPW, Holzapfel BM, Meckel T, Hutmacher DW, Loessner D. (2014).‘Gelatine methacrylamide-based hydrogels: an alternative three-dimensional cancer cell culture system’. Acta Biomater. 2014 Jun;10(6):2551-62. Epub 2014 Feb 28.